Poland· PL-100007341
Arduan
A pipecuronium bromide product containing pipecuronii bromidum, registered in Poland by Gedeon Richter Plc.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pipecuronium bromide is registered in 2 of 19 countries.
Countries holding a registration under ATC M03AC06 (pipecuronium bromide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Pipecuronium bromide · ATC M03AC06
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Pipecuronii bromidum
- Manufacturer
- Gedeon Richter Plc.
- Country
- Poland (PL)
- ATC code
- M03AC06
- ATC class
- Pipecuronium bromide
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990116713
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
49 interactions on record for pipecuronium bromide.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pipecuronium bromide · interactions on record
49 records
- 12 severe
- 33 moderate
- 4 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pipecuronium bromide in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Bulgaria · Ардуан
- Czechia · Arduan
- Hungary · Arduan
- Latvia · Arduan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/277a8d2e-61a5-47eb-89f9-76ecf1ff1905 GET /v1/drugs/277a8d2e-61a5-47eb-89f9-76ecf1ff1905?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "4 mg",
"packaging": "Lz ¦ Skasowane ¦ 1114\n5 fiol. s.subst. + rozp. 2 ml\n05909990116713 ¦ Lz ¦ 1115\n25 fiol. proszku + 25 amp. rozp.",
"substance": "Pipecuronii bromidum 4 mg",
"common_name": "Pipecuronii bromidum",
"pl_product_id": "100007341",
"pozwolenie_nr": "01167",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about pipecuronium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.